AzTrials
AzTrials

Depression, UnipolarNCT06139159

CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos

A study testing Outreach/navigator, Auxiliary to care and Stepped care and task shifting in people with Depression, Unipolar and Anxiety Disorders, run by Drexel University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Latinos in the U.S. experience significant disparities in access to mental health services due to lack of health insurance, language barriers, low availability of bilingual providers, mental health stigma, and fear of deportation. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Outreach/navigator, Auxiliary to care and Stepped care and task shifting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
603 participants
Where
1 siteUnited States
Study dates
10 Nov 2023to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ages 18-65
  • Fluent in English or Spanish
  • Self-identification as a member of the Latino community
  • Resident of Philadelphia, Bucks, Montgomery, Delaware, or Chester County.
  • Moderate to severe clinical symptoms of anxiety, depression, and/or PTSD

Who cannot join

  • People with high-risk mental health symptoms: active suicidality, substance use disorder, mania, psychosis, and schizophrenia
  • People already receiving mental health therapy (in the last 3 months)
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Drexel University School of Public Health

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Latinos in the U.S. experience significant disparities in access to mental health services due to lack of health insurance, language barriers, low availability of bilingual providers, mental health stigma, and fear of deportation. There is an urgent need to identify low-cost, culturally appropriate interventions to reduce mental health disparities among this population. This project will address that need by implementing and testing CRISOL Mente, a multi-level, culturally-congruent community intervention to improve the mental health of the Latino population in Philadelphia.

Read the detailed description

Latinos in the U.S. experience significant disparities in access to mental health services due to lack of health insurance, cost of services, limited awareness of mental health resources, mental health stigma, and fear of deportation. Limited English proficiency coupled with an acute lack of bilingual and culturally competent providers further impede Latinos' adequate access to quality mental health services. The COVID-19 pandemic has only amplified the need for mental health care and exacerbated mental health disparities for Latino communities, making it urgent to identify low-cost, effective strategies to reduce these gaps. This 5-year project seeks to develop and test a multi-level, community intervention to improve mental health outcomes and promote access to culturally appropriate mental health treatment for Latino communities in Philadelphia. CRISOL Mente will include components at various levels of the socio-ecological model: a clinic-based, stepped-care program relying on Latino lay health workers (LHW) for the delivery of mental health services.

To improve mental health symptoms and engagement in care, the investigators will recruit, train and supervise a cohort of Latino LHW who will be embedded into two Latino-serving clinics, extending the reach and effectiveness of the clinics' mental health services. The investigators will compare the impact of three different levels of LHW involvement: a) community outreach/navigation (i.e. screening and referral of community members); b) auxiliary care (i.e. screening, referral, and help overcoming barriers to better mental health); and c) task shifting (i.e. screening, referral, assistance, and supervised delivery of basic mental health treatment). The LHWs will also conduct outreach/education activities in the community (e.g. radio talks, info sessions, tables in community venues) to reduce mental health stigma. Our experienced and largely Latino community-academic research team will also engage in capacity building activities (i.e. monthly town halls, annual retreats, weekly newsletters, provision of trainings and technical support) with the Latino Health Collective, a coalition of Latino-serving organizations. Using mixed-methods and the RE-AIM framework, CRISOL Mente's impact will be evaluated with clinical data, baseline and 6-month patient survey data (N=200 from each level of LHW involvement, total n=600).

Being tested
Outreach/navigator, Auxiliary to care, Stepped care and task shifting
Keywords
Mental health, Latino health, Immigrant health, Community-health worker
Medical subject headings
Depressive Disorder, Anxiety Disorders, Stress Disorders, Post-Traumatic, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Outreach/navigatorOther

    Also called Phase 1

    • Conduct outreach activities with people in the community who are hard to reach and with limited access to health care, conduct informal screening for symptoms of mental illnesses, encourage and refer individuals at-risk, suspected of having, or affected by mental health issues to clinics for triage.
    • Document outreach, screening, and referral activities in LHW database
  • Auxiliary to careOther

    Also called Phase 2

    • Arrange consultation for those at-risk, suspected, or affected individuals at clinics for triage.
    • Introduce the patient to the clinical team via a "warm hand-off" and assist in scheduling a follow -up visit.
    • Support patients in attending their clinic visits; help patients address barriers through education, referral, and navigation to ancillary community services (SAVAME, legal, housing, economic, etc);
    • Engage, activate, and empower patients to participate in the care process
    • Frequent contact with patients: +1 every two weeks during the first 3 months, +1 every month for months 4-6.
    • Assist with group sessions: affinity groups
    • Identify community-based resources.
    • Document outreach, screening, referral, and auxiliary care activities in LHW database
  • Stepped care and task shiftingOther

    Also called Phase 3

    • Support counselling initiated by the psychologist
    • Reinforce patient education about depression, anxiety, trauma, and other syndemic conditions.
    • Work with patients' families and peers to reduce stigma, address syndemic factors and social conditions.
    • Contact frequency with patients: +1 every two weeks during the first 3 months, +1 every month for months 4-6.
    • Co-lead group sessions: affinity groups
    • Provide Mental Health First Aid to members of the community.
    • Document outreach, screening, referral, auxiliary and stepped care activities in LHW database
Study groups in NCT06139159
Study groupRoleWhat they receive
LHW as outreach agents/navigatorsExperimentalConduct outreach activities with people in the community who are hard to reach and with limited access to health care, conduct screening for symptoms of mental illnesses, encourage and refer individuals at-risk, suspected of having, or affected by mental health issues for further triage.
Receives: Other: Outreach/navigator
LHW as navigators and auxiliary to careExperimentalLHW continue conducting outreach and referral activities but in addition, LHW are more involved in their care. They arrange consultations, introduce the patient to the clinical team via a "warm hand-off" and assist in scheduling a follow-up visit, help patients comply with the follow-up appointments, help reduce patient and system barriers impeding their care; help patients address barriers through education, referral, and navigation to ancillary community services. They have frequent contact with the patient.
Receives: Other: Outreach/navigator; Other: Auxiliary to care
LHW stepped care and task shiftingExperimentalLHW conduct activities of prior arms but in addition, they may provide specific components of mental health care (task-shifting), providing components of basic evidence-based treatments to patients with non-complex needs, and addressing other syndemic health and social conditions.
Receives: Other: Outreach/navigator; Other: Auxiliary to care; Other: Stepped care and task shifting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement in mental health symptomatology (depressive, anxiety or post-traumatic stress disorder [PTSD])

    Improvement is a composite measure defined as change in any of the mental health outcomes. The following scales and categories will be used to define improvement.

    • Depressive symptoms: decrease in from CESD-10 at bsl >=10 to CESD-10 <10 at 6-month, among those with CESD-10 >=10 at baseline, OR
    • Anxiety symptoms: decrease in GAD7 category from bsl to 6-month: from 15-21(severe) to 10-14 (moderate) or from 15-21(severe) to less than 10 (mild or minimal anxiety), or from 10-14 bsl (moderate) to less than 10 (mild or minimal anxiety), among those with GAD7 >=10 at baseline, OR
    • For PTSD, decrease from in PTSD category from bsl to 6 months: from >=3 to PTSD <3, among those with PTSD>=3 at baseline).

    Measured: Baseline to 6 months

Secondary outcomes (3)
  1. Depressive symptomatology

    Presence or absence of any clinical mental health disorder will be determined using Center for Measured using Epidemiologic Studies Depression Scale Revised (CESD-R10) for depressive symptoms (continuously)

    Measured: Baseline to 6 months

  2. Anxiety symptomatology

    Measured using General Anxiety Disorder-7 (GAD-7) scale for anxiety symptoms (continuosly)

    Measured: Baseline to 6 months

  3. Post traumatic stress disorder symptomatology

    Measured using the Short Screening Scale for post-traumatic stress disorder (PTSD).

    Measured: Baseline to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2023
  2. Study start10 Nov 2023
  3. Primary completion31 Aug 2027 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Sequential
Model description
Our team vision is to develop a multi-level community-based model that is more pragmatic, efficient and effective than programs that address only one level of the socioecological model or rely solely on highly trained mental health professionals, who do not always have the necessary cultural or linguistical competency and are not affordable to many Latino-serving organizations. By tackling multiple levels and domains of influence, and leveraging heavily on cultural and context concordant actors, this project can pave the way for a new, scalable, and sustainable model to improve mental health and mental health treatment among Latino communities in the U.S. The comparison of the three phases can help to identify the optimal level of involvement by the LHWs.
Masking
None (open label)
Enrolment
603 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06139159
Sponsor's protocol ID
R01MD018206
Status last verified
Apr 2026
First submitted
15 Nov 2023
Last updated
15 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Outreach/navigator, Auxiliary to care and Stepped care and task shifting in people with Depression, Unipolar and Anxiety Disorders, run by Drexel University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement in mental health symptomatology (depressive, anxiety or post-traumatic stress disorder [PTSD]) (time frame: Baseline to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in